Tango Therapeutics, Inc. (TNGX) Ownership

$3.05

south_east
-$0.1 (-3.17%)
Day's range
$3.02
Day's range
$3.25

Tango Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
TRV GP IV, LLC 02/13/2025 16.86 M $52.09 M   0.00% 15.54%
TCG CROSSOVER MANAGEMENT, LLC 02/14/2025 10.74 M $33.17 M   100.00% 9.89%
ECOR1 CAPITAL, LLC 02/14/2025 10.63 M $32.85 M   -20.25% 9.80%
02/14/2025 10.38 M $32.08 M   100.00% 9.57%
NEXTECH INVEST LTD. 02/14/2025 5.53 M $17.10 M   0.00% 5.10%
GILEAD SCIENCES, INC. 02/13/2025 4.85 M $15.00 M   100.00% 4.47%
BLACKROCK FUNDING, INC. /DE 02/07/2025 4.38 M $13.53 M   0.39% 4.04%
FARALLON CAPITAL MANAGEMENT LLC 02/14/2025 4.00 M $12.36 M   100.00% 3.69%
VANGUARD GROUP INC 02/11/2025 3.99 M $12.31 M   9.32% 3.67%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 02/14/2025 3.35 M $10.34 M   -33.40% 3.08%
BALYASNY ASSET MANAGEMENT L.P. 02/14/2025 3.28 M $10.13 M   22.03% 3.02%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/14/2025 2.80 M $8.67 M   100.00% 2.58%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 02/14/2025 2.71 M $8.38 M   0.00% 2.50%
SIREN, L.L.C. 02/14/2025 2.60 M $8.05 M   0.00% 2.40%
BLUE OWL CAPITAL HOLDINGS LP 02/14/2025 1.73 M $5.35 M   100.00% 1.60%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.39 M $4.29 M   1.33% 1.28%
CASDIN CAPITAL, LLC 02/14/2025 1.19 M $3.67 M   0.00% 1.10%
ARROWMARK COLORADO HOLDINGS LLC 02/14/2025 708,385 $2.19 M   0.00% 0.65%
BESSEMER GROUP INC 02/13/2025 708,384 $2.19 M   0.00% 0.65%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 662,776 $2.05 M   83.75% 0.61%
SCHRODER INVESTMENT MANAGEMENT GROUP 02/12/2025 655,158 $2.03 M   100.00% 0.60%
SAMSARA BIOCAPITAL, LLC 02/14/2025 630,000 $1.95 M   0.00% 0.58%
ORBIMED ADVISORS LLC 02/14/2025 550,000 $1.70 M   100.00% 0.51%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 513,429 $1.59 M   5.38% 0.47%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 495,106 $1.53 M   100.00% 0.46%
GOLDMAN SACHS GROUP INC 02/11/2025 486,888 $1.50 M   -10.42% 0.45%
SUPERSTRING CAPITAL MANAGEMENT LP 02/14/2025 474,955 $1.47 M   -20.72% 0.44%
UBS GROUP AG 02/14/2025 414,473 $1.28 M   -5.98% 0.38%
WOODLINE PARTNERS LP 02/14/2025 394,397 $1.22 M   100.00% 0.36%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 02/14/2025 347,271 $1.07 M   100.00% 0.32%
WALLEYE CAPITAL LLC 02/13/2025 287,052 $886,991   101.33% 0.26%
MILLENNIUM MANAGEMENT LLC 02/14/2025 249,646 $771,406   100.00% 0.23%
CONGRESS ASSET MANAGEMENT CO /MA 01/30/2025 227,989 $704,486   9.05% 0.21%
TRV GP VI, LLC 02/13/2025 194,174 $599,998   100.00% 0.18%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 192,259 $594,080   -6.13% 0.18%
ALGERT GLOBAL LLC 02/14/2025 162,300 $502,000   100.00% 0.15%
FISHER ASSET MANAGEMENT, LLC 02/05/2025 154,947 $478,786   0.00% 0.14%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 138,247 $427,183   -3.46% 0.13%
FRANKLIN RESOURCES INC 02/12/2025 126,553 $391,049   670.40% 0.12%
EXODUSPOINT CAPITAL MANAGEMENT, LP 02/12/2025 121,993 $377,000   100.00% 0.11%
D. E. SHAW & CO., INC. 02/14/2025 114,827 $354,815   100.00% 0.11%
AMERICAN CENTURY COMPANIES INC 02/11/2025 110,448 $341,284   12.37% 0.10%
BANK OF NEW YORK MELLON CORP 02/04/2025 103,020 $318,331   -7.80% 0.09%
PDT PARTNERS, LLC 02/14/2025 102,807 $317,674   100.00% 0.09%
BARCLAYS PLC 02/13/2025 99,774 $307,000   -20.99% 0.09%
JANE STREET GROUP, LLC 02/14/2025 95,229 $294,258   87.59% 0.09%
SWISS NATIONAL BANK 02/10/2025 94,900 $293,241   13.11% 0.09%
GSA CAPITAL PARTNERS LLP 02/07/2025 86,445 $267,000   90.95% 0.08%
VERITION FUND MANAGEMENT LLC 02/14/2025 81,045 $250,429   153.11% 0.07%
XTX TOPCO LTD 02/13/2025 77,937 $240,825   76.36% 0.07%

Tango Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 157 institutional investors and hedge funds held shares of Tango Therapeutics, Inc.. The most heavily invested institutionals were:

TRV GP IV, LLC: 16.86 M

TCG Crossover Management, LLC: 10.74 M

EcoR1 Capital, LLC: 10.63 M

Nextech Invest Ltd.: 5.53 M

GILEAD SCIENCES, INC.: 4.85 M

BlackRock Funding, Inc. /DE: 4.38 M

98.10% of Tango Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 107.80 M shares in the last 24 months. This purchase volume represents approximately $328.80 M in transactions.